Innovative care protocol successfully rehabilitates non-human primates after MPTP-induced parkinsonism: Preliminary evidence from a restricted cohort of African Green Monkeys ( Chlorocebus sabaeus )
Authors:
- 13 March 2025
- journal article
- Published by SAGE Publications in Laboratory Animals
- Vol. 59 (4) , 523-529
Abstract
The MPTP-animal model of Parkinson’s disease has significantly advanced our understanding of Parkinson’s disease and the dopaminergic system, helping to establish disease mechanisms and develop therapeutic targets. The non-human primate (NHP) MPTP model is particularly valuable for replicating core Parkinson’s disease motor symptoms, anatomical changes and electrophysiological variations seen in humans. However, MPTP-injection protocols often cause substantial suffering, leading to euthanasia. While some post-MPTP primates recovered spontaneously, purposefully induced recovery was considered unattainable. Our team developed a novel intensive care protocol (NICP) promoting complete recovery from MPTP-induced severe parkinsonism in NHPs. NICP provides therapeutic, nutritional and social support, enabling behavioral recovery and subsequent retirement to a primate sanctuary. This innovation enhances animal welfare and opens new prospects for veterinary care, emphasizing the need to explore recovery mechanisms for other chronic conditions induced for research.Keywords
Funding Information
- Edmund and Lily Safra Brain Center
- Israel Science Foundation
- Rosetrees and Adelis Foundation
This publication has 21 references indexed in Scilit:
- Toward asleep DBS: cortico-basal ganglia spectral and coherence activity during interleaved propofol/ketamine sedation mimics NREM/REM sleep activitynpj Parkinson's Disease, 2021
- Longer β oscillatory episodes reliably identify pathological subthalamic activity in ParkinsonismMovement Disorders, 2018
- Modeling Parkinson's disease in monkeys for translational studies, a critical analysisExperimental Neurology, 2014
- Closed-Loop Deep Brain Stimulation Is Superior in Ameliorating ParkinsonismNeuron, 2011
- Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatmentNeuroscience, 1999
- Spontaneous Blink Rates Correlate with Dopamine Levels in the Caudate Nucleus of MPTP-Treated MonkeysExperimental Neurology, 1999
- Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot studyEuropean Journal of Pharmacology, 1995
- Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxinNeuropharmacology, 1989
- Animal Models of Parkinsonism Using Selective Neurotoxins: Clinical and Basic Implications1989
- Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeysNeuroscience, 1986